Evidence map›Paper›PMID 26907873›Full record

ArticleInternational orthopaedics2016

Testing of antibiotic releasing implant coatings to fight bacteria in combat-associated osteomyelitis - an in-vitro study.

David Alexander Back, Nicole Bormann, Arash Calafi, Julie Zech, Leif Alexander Garbe, Martin Müller, Christian Willy, Gerhard Schmidmaier, Britt Wildemann

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. CORR InsightsClinical orthopaedics and related research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

David Alexander BackDepartment of Traumatology and Orthopaedics, Septic and Reconstructive Surgery, Bundeswehr Hospital Berlin, Scharnhorststrasse 13, 10115, Berlin, Germany. david.back@charite.de.
Nicole BormannJulius Wolff Institute and Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Arash CalafiDepartment of Orthopedic Surgery, University of California, Davis, CA, USA.
Julie ZechDepartment of Biotechnology, Institute of Bioanalytics, Technische Universität Berlin, Berlin, Germany.
Leif Alexander GarbeDepartment of Biotechnology, Institute of Bioanalytics, Technische Universität Berlin, Berlin, Germany.
Martin MüllerDepartment of Medicine, Central Institute of the Bundeswehr Medical Service Kiel, Berlin Branch, Berlin, Germany.
Christian WillyDepartment of Traumatology and Orthopaedics, Septic and Reconstructive Surgery, Bundeswehr Hospital Berlin, Scharnhorststrasse 13, 10115, Berlin, Germany.
Gerhard SchmidmaierDepartment for Orthopaedics, Traumatology and Paraplegiology, University of Heidelberg, Heidelberg, Germany.
Britt WildemannJulius Wolff Institute and Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DEBundeswehrkrankenhaus · DEBundeswehr Medical Service Academy · DEHeidelberg University · DETechnische Universität Berlin · DEUniversity of California, Davis · USVersuchs- und Lehranstalt für Brauerei in Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSurgical procedures to prevent osteomyelitis after trauma can be supported by local application of antibiotics. This in-vitro study investigated the release and impact of antibiotics from implant coatings against bacteria associated with combat-related osteomyelitis.

methodsK-wires were coated with poly(D,L-lactide) and ciprofloxacin, gentamicin, colistin, daptomycin or cefoxitin in different concentrations. The release was quantified and antimicrobial activity tested for different gram-positive or gram-negative bacteria, alone and in combination. To exclude toxic effects, primary osteoblast-like cells were exposed to antibiotic coating concentrations.

resultsAll antibiotics alone and in combination showed an initial burst release with dose dependent antimicrobial activity and no negative effects on osteoblast-like cells, except for cefoxitin.

conclusionsImplant coatings can be customized with single or double antibiotic coatings to effectively fight different bacteria and also mixed infections in the treatment of a combat-acquired osteomyelitis. However, optimal drug load and degradation behaviour of individual antibiotics have to be considered.

Indexed as

Bone WiresProstheses and ImplantsAnti-Bacterial AgentsBacteriaCell Culture TechniquesHumansIn Vitro TechniquesOsteomyelitisWar-Related InjuriesAnti-Bacterial AgentsAntibioticsBacteriaCombat injuryImplant coatingOrthopaedic infectionsOsteomyelitisPDLLA

Identifiers

PMID26907873
OpenAlexW2276876495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.